Literature DB >> 31813803

Multiple rare inherited variants in a four generation schizophrenia family offer leads for complex mode of disease inheritance.

Jibin John1, Upasana Bhattacharyya2, Navneesh Yadav2, Prachi Kukshal2, Triptish Bhatia3, V L Nimgaonkar4, Smita N Deshpande3, B K Thelma5.   

Abstract

Schizophrenia is a clinically and genetically heterogeneous neuropsychiatric disorder, with a polygenic basis but identification of the specific determinants is a continuing challenge. In this study, we analyzed a multigenerational family, with all healthy individuals in the first two generations, and four progeny affected with schizophrenia in the subsequent two generations, using whole exome sequencing. We identified five rare protein sequence altering heterozygous variants, in five different genes namely SMARCA5, PDE1B, TNIK, SMARCA2 and FLRT shared among all affected members and predicted to be damaging. Variants in SMARCA5 and PDE1B were inherited from the unaffected father whereas variants in TNIK, SMARCA2 and FLRT1 were inherited from the unaffected mother in all the three affected individuals in the third generation; and notably all these five variants were transmitted by an affected mother to her affected son. Microsatellite based analysis lent a modest linkage support (LOD score of 1.2; θ=0.0 at each variant). Of note, analysis of exome data of an ancestry matched unrelated schizophrenia cohort (n = 350), revealed a total of 16 rare variants (MAF < 0.01) in these five genes. Interestingly, these five genes involved in neurodevelopmental and/or neurotransmitter signaling processes are implicated in the etiology of schizophrenia previously. This study provides good evidence for a likely cumulative contribution of multiple rare variants from disease relevant genes with a threshold effect in disease development and seems to explain the unusual disease transmission pattern generally witnessed in such conditions, but warrants extensive replication efforts in families with similar complex disease inheritance profiles.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Epigenetics; Exome sequencing; Neurodevelopment; Oligogenic; Schizophrenia; TNIK

Mesh:

Year:  2019        PMID: 31813803      PMCID: PMC8958857          DOI: 10.1016/j.schres.2019.11.041

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  76 in total

1.  SMARCA2 and other genome-wide supported schizophrenia-associated genes: regulation by REST/NRSF, network organization and primate-specific evolution.

Authors:  Yann Loe-Mie; Aude-Marie Lepagnol-Bestel; Gilles Maussion; Adi Doron-Faigenboim; Sandrine Imbeaud; Hervé Delacroix; Lawrence Aggerbeck; Tal Pupko; Philip Gorwood; Michel Simonneau; Jean-Marie Moalic
Journal:  Hum Mol Genet       Date:  2010-05-10       Impact factor: 6.150

2.  Rare PDCD11 variations are not associated with risk of schizophrenia in Japan.

Authors:  Satoshi Hoya; Yuichiro Watanabe; Akitoyo Hishimoto; Ayako Nunokawa; Naoshi Kaneko; Tatsuyuki Muratake; Naofumi Shinmyo; Ikuo Otsuka; Shujiro Okuda; Emiko Inoue; Hirofumi Igeta; Masako Shibuya; Jun Egawa; Naoki Orime; Ichiro Sora; Toshiyuki Someya
Journal:  Psychiatry Clin Neurosci       Date:  2017-07-31       Impact factor: 5.188

3.  The psychiatric disease risk factors DISC1 and TNIK interact to regulate synapse composition and function.

Authors:  Q Wang; E I Charych; V L Pulito; J B Lee; N M Graziane; R A Crozier; R Revilla-Sanchez; M P Kelly; A J Dunlop; H Murdoch; N Taylor; Y Xie; M Pausch; A Hayashi-Takagi; K Ishizuka; S Seshadri; B Bates; K Kariya; A Sawa; R J Weinberg; S J Moss; M D Houslay; Z Yan; N J Brandon
Journal:  Mol Psychiatry       Date:  2010-09-14       Impact factor: 15.992

Review 4.  Integrative nuclear signaling in cell development--a role for FGF receptor-1.

Authors:  Michal K Stachowiak; Pamela A Maher; Ewa K Stachowiak
Journal:  DNA Cell Biol       Date:  2007-12       Impact factor: 3.311

Review 5.  Schizophrenia.

Authors:  René S Kahn; Iris E Sommer; Robin M Murray; Andreas Meyer-Lindenberg; Daniel R Weinberger; Tyrone D Cannon; Michael O'Donovan; Christoph U Correll; John M Kane; Jim van Os; Thomas R Insel
Journal:  Nat Rev Dis Primers       Date:  2015-11-12       Impact factor: 52.329

6.  Glutamatergic antipsychotic drugs: a new dawn in the treatment of schizophrenia?

Authors:  James M Stone
Journal:  Ther Adv Psychopharmacol       Date:  2011-02

7.  Synaptic, transcriptional and chromatin genes disrupted in autism.

Authors:  Silvia De Rubeis; Xin He; Arthur P Goldberg; Christopher S Poultney; Kaitlin Samocha; A Erucment Cicek; Yan Kou; Li Liu; Menachem Fromer; Susan Walker; Tarinder Singh; Lambertus Klei; Jack Kosmicki; Fu Shih-Chen; Branko Aleksic; Monica Biscaldi; Patrick F Bolton; Jessica M Brownfeld; Jinlu Cai; Nicholas G Campbell; Angel Carracedo; Maria H Chahrour; Andreas G Chiocchetti; Hilary Coon; Emily L Crawford; Sarah R Curran; Geraldine Dawson; Eftichia Duketis; Bridget A Fernandez; Louise Gallagher; Evan Geller; Stephen J Guter; R Sean Hill; Juliana Ionita-Laza; Patricia Jimenz Gonzalez; Helena Kilpinen; Sabine M Klauck; Alexander Kolevzon; Irene Lee; Irene Lei; Jing Lei; Terho Lehtimäki; Chiao-Feng Lin; Avi Ma'ayan; Christian R Marshall; Alison L McInnes; Benjamin Neale; Michael J Owen; Noriio Ozaki; Mara Parellada; Jeremy R Parr; Shaun Purcell; Kaija Puura; Deepthi Rajagopalan; Karola Rehnström; Abraham Reichenberg; Aniko Sabo; Michael Sachse; Stephan J Sanders; Chad Schafer; Martin Schulte-Rüther; David Skuse; Christine Stevens; Peter Szatmari; Kristiina Tammimies; Otto Valladares; Annette Voran; Wang Li-San; Lauren A Weiss; A Jeremy Willsey; Timothy W Yu; Ryan K C Yuen; Edwin H Cook; Christine M Freitag; Michael Gill; Christina M Hultman; Thomas Lehner; Aaarno Palotie; Gerard D Schellenberg; Pamela Sklar; Matthew W State; James S Sutcliffe; Christiopher A Walsh; Stephen W Scherer; Michael E Zwick; Jeffrey C Barett; David J Cutler; Kathryn Roeder; Bernie Devlin; Mark J Daly; Joseph D Buxbaum
Journal:  Nature       Date:  2014-10-29       Impact factor: 49.962

8.  Whole-genome sequencing in multiplex families with psychoses reveals mutations in the SHANK2 and SMARCA1 genes segregating with illness.

Authors:  O R Homann; K Misura; E Lamas; R W Sandrock; P Nelson; S I McDonough; L E DeLisi
Journal:  Mol Psychiatry       Date:  2016-03-22       Impact factor: 15.992

9.  De novo mutations in schizophrenia implicate synaptic networks.

Authors:  Menachem Fromer; Andrew J Pocklington; David H Kavanagh; Hywel J Williams; Sarah Dwyer; Padhraig Gormley; Lyudmila Georgieva; Elliott Rees; Priit Palta; Douglas M Ruderfer; Noa Carrera; Isla Humphreys; Jessica S Johnson; Panos Roussos; Douglas D Barker; Eric Banks; Vihra Milanova; Seth G Grant; Eilis Hannon; Samuel A Rose; Kimberly Chambert; Milind Mahajan; Edward M Scolnick; Jennifer L Moran; George Kirov; Aarno Palotie; Steven A McCarroll; Peter Holmans; Pamela Sklar; Michael J Owen; Shaun M Purcell; Michael C O'Donovan
Journal:  Nature       Date:  2014-01-22       Impact factor: 49.962

10.  Constitutively active Rap2 transgenic mice display fewer dendritic spines, reduced extracellular signal-regulated kinase signaling, enhanced long-term depression, and impaired spatial learning and fear extinction.

Authors:  Jubin Ryu; Kensuke Futai; Monica Feliu; Richard Weinberg; Morgan Sheng
Journal:  J Neurosci       Date:  2008-08-13       Impact factor: 6.167

View more
  5 in total

1.  Two Genetic Mechanisms in Two Siblings with Intellectual Disability, Autism Spectrum Disorder, and Psychosis.

Authors:  Yu-Shu Huang; Ting-Hsuan Fang; Belle Kung; Chia-Hsiang Chen
Journal:  J Pers Med       Date:  2022-06-20

2.  A linkage and exome study of multiplex families with bipolar disorder implicates rare coding variants of ANK3 and additional rare alleles at 10q11-q21.

Authors:  Claudio Toma; Alex D Shaw; Anna Heath; Kerrie D Pierce; Philip B Mitchell; Peter R Schofield; Janice M Fullerton
Journal:  J Psychiatry Neurosci       Date:  2021-03-17       Impact factor: 6.186

3.  Rare Pathogenic Variants in Genes Implicated in Glutamatergic Neurotransmission Pathway Segregate with Schizophrenia in Pakistani Families.

Authors:  Ambrin Fatima; Uzma Abdullah; Muhammad Farooq; Yuan Mang; Mana M Mehrjouy; Maria Asif; Zafar Ali; Niels Tommerup; Shahid M Baig
Journal:  Genes (Basel)       Date:  2021-11-26       Impact factor: 4.096

4.  Involvement of Rare Mutations of SCN9A, DPP4, ABCA13, and SYT14 in Schizophrenia and Bipolar Disorder.

Authors:  Chia-Hsiang Chen; Yu-Shu Huang; Ting-Hsuan Fang
Journal:  Int J Mol Sci       Date:  2021-12-07       Impact factor: 5.923

Review 5.  Precision medicine and therapies of the future.

Authors:  Sanjay M Sisodiya
Journal:  Epilepsia       Date:  2020-07-24       Impact factor: 6.740

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.